España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

esteve pharmaceuticals s.a. - itraconazol - cÁpsula dura - 100 mg - itraconazol 100 mg - itraconazol

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

isdin s.a. - itraconazol - cÁpsula dura - 100 mg - itraconazol 100 mg - itraconazol

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

laboratorios alter s.a. - itraconazol - cÁpsula dura - 100 mg - itraconazol 100 mg - itraconazol

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

sandoz farmaceutica s.a. - itraconazol - cÁpsula dura - 100 mg - itraconazol 100 mg - itraconazol

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

janssen cilag s.a. - itraconazol - cÁpsula dura - 100 mg - itraconazol 100 mg - itraconazol

Perú - español - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

laboratorios ac farma s.a. - itraconazol; - capsula - por capsula - itraconazol

Unión Europea - español - EMA (European Medicines Agency)

bayer ag - riociguat - hipertensión, pulmonar - antihipertensivos para la hipertensión arterial pulmonar - chronic thromboembolic pulmonary hypertension (cteph)adempas is indicated for the treatment of adult patients with who functional class (fc) ii to iii withinoperable cteph,persistent or recurrent cteph after surgical treatment,to improve exercise capacity. pulmonary arterial hypertension (pah)adultsadempas, as monotherapy or in combination with endothelin receptor antagonists, is indicated for the treatment of adult patients with pulmonary arterial hypertension (pah) with who functional class (fc) ii to iii to improve exercise capacity. la eficacia se ha demostrado en un pah la población, incluyendo a las etiologías de la idiopático o hereditario hap o pah asociada con enfermedad del tejido conectivo. paediatricsadempas is indicated for the treatment of pah in paediatric patients aged less than 18 years of age and body weight ≥ 50 kg with who functional class (fc) ii to iii in combination with endothelin receptor antagonists.

Unión Europea - español - EMA (European Medicines Agency)

abbvie deutschland gmbh co. kg - glecaprevir, pibrentasvir - hepatitis c, crónica - antivirales para uso sistémico - maviret is indicated for the treatment of chronic hepatitis c virus (hcv) infection in adults and children aged 3 years and older. maviret coated granules is indicated for the treatment of chronic hepatitis c virus (hcv) infection in children 3 years and older.

Perú - español - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

abbvie sas, sucursal del peru - tableta recubierta - por mililitro - antivirales de acciÓn directa

Unión Europea - español - EMA (European Medicines Agency)

pfizer europe ma eeig - lorlatinib - carcinoma, pulmón no microcítico - antineoplastic agents, protein kinase inhibitors - lorviqua as monotherapy is indicated for the treatment of adult patients with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc) previously not treated with an alk inhibitor. lorviqua as monotherapy is indicated for the treatment of adult patients with alk‑positive advanced nsclc whose disease has progressed after:alectinib or ceritinib as the first alk tyrosine kinase inhibitor (tki) therapy; orcrizotinib and at least one other alk tki.